Summary
In order to assess the effect of felodipine, a new calcium antagonist with vascular selectivity, on regional blood flow distribution at rest in chronic congestive heart failure, ten patients were studied during an acute test. Right heart catheterization allowed the evaluation of hemodynamic parameters; renal blood flow was calculated using paraamino-hippuric acid clearance; hepatic blood flow measurement was based on indocyanine green clearance; and limb blood flow was assessed with venous occlusion plethysmography. Blood samples were collected for the analysis of plasma catecholamines, renin, and aldosterone. All parameters were recorded in duplicate under basal conditions and after felodipine infusion.
The infusion of felodipine induced a significant increase in cardiac index, stroke work index, and limb blood flow. Systemic and pulmonary arterial blood pressure, pulmonary wedge pressure, and systemic resistance underwent a significant decrease. The heart rate, pulmonary resistance, renal blood flow, and hepatic blood flow were not changed.
In conclusion, felodipine was of benefit in congestive heart failure at rest in an acute test, acting through a marked decrease in vascular resistance and a consequent improvement in cardiac output and limb blood flow. No changes in renal and hepatic blood flow were observed.
Similar content being viewed by others
References
Fagard R, Lijnen P, Moerman E, et al. Acute haemodynamic and humoral responses to felodipine and metoprolol in mild hypertension.Eur J Clin Pharmacol 1987; 32:71–75.
Elmfeldt D, Hedner T. Felodipine, a new vasodilator, in addition to beta-receptor blockade in hypertension.Eur J Clin Pharmacol 1983; 25:571–575.
Leonetti G, Gradnik R, Terzoli L, et al. Felodipine, a new vasodilating drug: Blood pressure, cardiac, renal, and humoral effects in hypertensive patients.J Cardiovasc Pharmacol 1984; 6:392–398.
Wathen CG, MacLeod D, Tucker L, et al. Felodipine as a replacement for minoxidil in the treatment of severe hypertension.Eur Heart J 1986; 7:893–897.
Sheridan JV, Thomas P, Routledge PA, et al. Effects of felodipine on hemodynamics and exercise capacity in patients with angina pectoris.Br J Clin Pharmacol 1987; 23:391–396.
Detry JMR, De Coster PM, Renkin J. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.Am J Cardiol 1983; 52:453–457.
Tweddel AC, Johnsson G, Pringle TH, et al. The systemic and coronary hemodynamic effects of felodipine in patients with coronary heart disease.Eur Heart J 1983; 4:699–705.
Tan LB, Murray RG, Littler WA. Felodipine in patients with chronic heart failure: discrepant hemodynamic and clinical effects.Br Heart J 1987; 58:122–128.
Kassis E, Amtorp O, Waldorff S, et al. Efficacy of felodipine in chronic congestive heart failure: a placebo controlled hemodynamic study at rest and during exercise and orthostatic stress.Br Heart J 1987; 58:505–511.
Tweddel AC, Hutton I. Felodipine in ventricular dysfunction.Eur Heart J 1986; 7:54–60.
Binetti G, Pancaldi S, Giovanelli N, et al. Hemodynamic effects of felodipine in congestive heart failure.Cardiovasc Drug Ther 1987; 1:161–167.
Daneshmend TK, Roberts LJ. Physiological and pharmacological variability in estimated hepatic blood flow in man.Br J Clin Pharmacol 1981; 11:491–496.
Ohnaus EE. Methods of the assessment of the effect of drugs on liver blood flow in man.Br J clin Pharmac 1979; 7:223–229.
Edgar B, Regardh CG, Lundborg P, et al. Pharmacokinetics and pharmacodynamic studies of felodipine in healthy subjects after various single, oral and intravenous doses.Biopharm Drug Dispos 1987; 8:235–248.
Sluiter HE, Huysmans FTM, Thien TA, et al. Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers.Drugs 1985; 29:26–35.
Ahnoff M. Determination of felodipine in plasma by gas chromatography with electron capture detection.J Pharm Biomed Ann 1984; 2:519–526.
Francis G. Neurohumoral mechanisms involved in congestive heart failure.Am J Cardiol 1985; 55:15A-21A.
Leithe C, Margorien RD, Hermiller JB, et al. Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure.Circulation 1984; 69:57–64.
Leier CV, Patrick TJ, Hermiller J, et al. Nifedipine in congestive heart failure: Effects on resting and exercise hemodynamics and regional blood flow.Am Heart J 1984; 108:1461–1468.
Levine TB, Olivari MT, Cohn JN. Hemodynamic and regional blood flow response to captopril in congestive heart failure.Am J Med 1984; 76 (5B):38–42.
Ventura HO, Frohlich ED, Messerli FH, et al. Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension.Am J Cardiol 1985; 55:1023–1026.
Cohn JN. Calcium antagonists and left ventricular function: Effects of nitrendipine in congestive heart failure.Am J Cardiol 1986; 58:27D-30D.
Leonetti G, Gradnik R, Terzoli L, et al. Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients.J Cardiovasc Pharmacol 1986; 8:1243–1248.
Schmitz A. Acute renal effects of oral felodipine in normal man.Eur J Clin Pharmacol 1987; 32:17–22.
Timmis AD, Smyth P, Kenny JF, et al. Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.Br Heart J 1984; 52:314–320.
Edgar B, Bengtsson B, Elmfeldt D, et al. Acute diuretic/natriuretic properties of felodipine in man.Drugs 1985; 29 (Suppl 2):176–184.
Leonetti G, Fruscio M, Terzoli L, et al. Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist in hypertensive patients.Drugs 1985; 29 (Suppl 2):185–191.
Naftilan AJ, Oparil S. The role of calcium in the control of renin release.Hypertension 1982; 4:670–675.
Andersson OK, Granerus G, Hedner T, et al. Systemic and renal hemodynamic effects of single oral doses of felodipine in patients with refractory hypertension receiving chronic therapy with β-blockers and diuretics.J Cardiovasc Pharmacol 1985; 7:544–549.
Elkayam U, Roth A, Hsueh W, et al. Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure.Am Heart J 1986; 111:1130–1138.
Barjon JN, Rouleau JL, Bichet D, et al. Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure.J Am Coll Cardiol 1987; 9:622–630.
Fifer MA, Colucci WS, Lorell BH, et al. Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: Comparison with nitroprusside.J Am Coll Cardiol 1985; 5:731–737.
Fakundig JL, Catt KJ. Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: Effects of lanthanum and verapamil.Endocrinology 1980; 107:1345–1353.
Kluger J, Cody RJ, Laragh JH. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: Response to specific inhibitors (prazosin and captopril).Am J Cardiol 1982; 49:1667–1674.
Markham RV, Gilmore A, Pettinger WA, et al. Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside.Am J Cardiol 1983; 52:774–781.
Author information
Authors and Affiliations
Additional information
Part of these data have been presented at the Second Cardiovascular Pharmacotherapy International Symposium, San Francisco, CA, 1987.
Rights and permissions
About this article
Cite this article
Binetti, G., Rubino, I., Varani, E. et al. Felodipine in severe chronic congestive heart failure: Acute effects on central hemodynamics and regional blood flow distribution. Cardiovasc Drug Ther 3, 903–911 (1989). https://doi.org/10.1007/BF01869580
Issue Date:
DOI: https://doi.org/10.1007/BF01869580